Negligible exposure to nifurtimox through breast milk during maternal treatment for Chagas Disease

Background: Treatment with nifurtimox (NF) for Chagas disease is discouraged during breast-feeding because no information on NF transfer into breast milk is available. NF is safe and effective for paediatric and adult Chagas disease. We evaluated the degree of NF transfer into breast milk in lactati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Moroni, Samanta, Marson, María Elena, Moscatelli, Guillermo, Mastrantonio Garrido, Guido Enrique, Bisio, Margarita, González, Nicolás, Ballering, Griselda, Altcheh, Jaime, Garcia Bournissen, Facundo
Formato: Articulo
Lenguaje:Inglés
Publicado: 2019
Materias:
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/126176
Aporte de:
id I19-R120-10915-126176
record_format dspace
institution Universidad Nacional de La Plata
institution_str I-19
repository_str R-120
collection SEDICI (UNLP)
language Inglés
topic Ciencias Médicas
Chagas disease
Internal medicine
Prospective cohort study
Breast milk
Breastfeeding
Blood plasma
Nifurtimox
Breast feeding
Medicine
Cohort
Gastroenterology
spellingShingle Ciencias Médicas
Chagas disease
Internal medicine
Prospective cohort study
Breast milk
Breastfeeding
Blood plasma
Nifurtimox
Breast feeding
Medicine
Cohort
Gastroenterology
Moroni, Samanta
Marson, María Elena
Moscatelli, Guillermo
Mastrantonio Garrido, Guido Enrique
Bisio, Margarita
González, Nicolás
Ballering, Griselda
Altcheh, Jaime
Garcia Bournissen, Facundo
Negligible exposure to nifurtimox through breast milk during maternal treatment for Chagas Disease
topic_facet Ciencias Médicas
Chagas disease
Internal medicine
Prospective cohort study
Breast milk
Breastfeeding
Blood plasma
Nifurtimox
Breast feeding
Medicine
Cohort
Gastroenterology
description Background: Treatment with nifurtimox (NF) for Chagas disease is discouraged during breast-feeding because no information on NF transfer into breast milk is available. NF is safe and effective for paediatric and adult Chagas disease. We evaluated the degree of NF transfer into breast milk in lactating women with Chagas disease. Patients and methods: Prospective study of a cohort of lactating women with Chagas disease. Patients were treated with NF for 1 month. NF was measured in plasma and milk by high performance liquid chromatography (HPLC). Breastfed infants were evaluated at admission, 7th and 30th day of treatment (and monthly thereafter, for 6 months). Results: Lactating women with chronic Chagas disease (N = 10) were enrolled (median age 28 years, range 17–36). Median NF dose was 9.75 mg/kg/day three times a day (TID). Six mothers had mild adverse drug reactions (ADRs), but no ADRs were observed in any of the breastfed infants. No interruption of breastfeeding was observed. Median NF concentrations were 2.15 mg/L (Inter quartil range (IQR) 1.32–4.55) in milk and 0.30 mg/L (IQR 0.20–0.95) in plasma. Median NF milk/plasma ratio was 16 (range 8.75–30.25). Median relative infant NF dose (assuming a daily breastmilk intake of 150 mL/kg/day) was 6.7% of the maternal dose/kg/day (IQR 2.35–7.19%). Conclusions: The low concentrations of NF in breast milk and the normal clinical evaluation of the breastfed babies imply that maternal NF treatment for Chagas disease during breastfeeding is unlikely to lead to clinically relevant exposures in the breastfed infants.
format Articulo
Articulo
author Moroni, Samanta
Marson, María Elena
Moscatelli, Guillermo
Mastrantonio Garrido, Guido Enrique
Bisio, Margarita
González, Nicolás
Ballering, Griselda
Altcheh, Jaime
Garcia Bournissen, Facundo
author_facet Moroni, Samanta
Marson, María Elena
Moscatelli, Guillermo
Mastrantonio Garrido, Guido Enrique
Bisio, Margarita
González, Nicolás
Ballering, Griselda
Altcheh, Jaime
Garcia Bournissen, Facundo
author_sort Moroni, Samanta
title Negligible exposure to nifurtimox through breast milk during maternal treatment for Chagas Disease
title_short Negligible exposure to nifurtimox through breast milk during maternal treatment for Chagas Disease
title_full Negligible exposure to nifurtimox through breast milk during maternal treatment for Chagas Disease
title_fullStr Negligible exposure to nifurtimox through breast milk during maternal treatment for Chagas Disease
title_full_unstemmed Negligible exposure to nifurtimox through breast milk during maternal treatment for Chagas Disease
title_sort negligible exposure to nifurtimox through breast milk during maternal treatment for chagas disease
publishDate 2019
url http://sedici.unlp.edu.ar/handle/10915/126176
work_keys_str_mv AT moronisamanta negligibleexposuretonifurtimoxthroughbreastmilkduringmaternaltreatmentforchagasdisease
AT marsonmariaelena negligibleexposuretonifurtimoxthroughbreastmilkduringmaternaltreatmentforchagasdisease
AT moscatelliguillermo negligibleexposuretonifurtimoxthroughbreastmilkduringmaternaltreatmentforchagasdisease
AT mastrantoniogarridoguidoenrique negligibleexposuretonifurtimoxthroughbreastmilkduringmaternaltreatmentforchagasdisease
AT bisiomargarita negligibleexposuretonifurtimoxthroughbreastmilkduringmaternaltreatmentforchagasdisease
AT gonzaleznicolas negligibleexposuretonifurtimoxthroughbreastmilkduringmaternaltreatmentforchagasdisease
AT balleringgriselda negligibleexposuretonifurtimoxthroughbreastmilkduringmaternaltreatmentforchagasdisease
AT altchehjaime negligibleexposuretonifurtimoxthroughbreastmilkduringmaternaltreatmentforchagasdisease
AT garciabournissenfacundo negligibleexposuretonifurtimoxthroughbreastmilkduringmaternaltreatmentforchagasdisease
bdutipo_str Repositorios
_version_ 1764820450168274946